Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intestinal epithelial tight-junction protein (TJ) refers to a complex network of transmembrane and cytosolic proteins that form a selective barrier between adjacent epithelial cells in the gut. This complex, which includes claudins, occludin, and zonula occludens (ZO) proteins, regulates the paracellular movement of water, ions, and nutrients while preventing the entry of pathogens and toxins from the lumen into the systemic circulation (Source: StatPearls, PMID: 30571025). Its primary biological role is to maintain the intestinal mucosal barrier and cell polarity (Source: NIH, PMID: 28123247). In pathological states like Celiac disease and Inflammatory Bowel Disease (IBD), the expression and localization of these proteins are disrupted, leading to increased intestinal permeability or "leaky gut" (Source: Frontiers in Immunology, PMID: 31275313). Pharmacological targeting of these proteins, such as with the zonulin antagonist larazotide acetate, aims to restore barrier integrity and mitigate autoimmune responses (Source: Journal of Pharmaceutical Sciences, PMID: 25611133). Additionally, temporary modulation of these proteins is explored as a strategy to enhance the oral bioavailability of poorly permeable drugs (Source: Advanced Drug Delivery Reviews, PMID: 23159811).
Antagonism of the zonulin receptor to prevent junction disassembly; upregulation of claudin and occludin expression to restore barrier integrity; stabilization of the perijunctional actin-myosin ring; activation of chloride channels to promote junctional assembly.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal epithelial tight-junction protein (TJ) (TJ).